| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.18 | 0.001 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.093 | 0.007 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |